Fundz

Odysight.ai

Omer, Israel · Artificial Intelligence, Biotechnology, Health Care

Odysight.ai is pioneering the Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) markets with its visualization and AI platform. Providing video sensor-based solutions for critical systems in the aviation, transportation, and energy industries, Odysight.ai leverages proven visual technologies and products from the medical industry. Odysight.ai’s unique video-based sensors, embedded

Key facts

Headquarters
Omer, Israel
Employees
56
Industries
Artificial Intelligence, Biotechnology, Health Care
Status
Public (ODYS)
Website
www.odysight.ai
LinkedIn
Company page

Recent activity at Odysight.ai

  • : Odysight.ai Inc. Secures $11 Million in Public Offering
  • : Odysight.ai Appoints Ronen Tanami as Chief Operating Officer
  • : SEC 8-K (1.01): On August 20, 2026, Odysight.ai Inc. entered into a Material Definitive Agreement by signing an underwriting agreement with Roth Capital Partners, LLC. This agreement pertains to a firm commitment underwritten public offering of 3,437,500 shares of the Company's common stock, priced at $3.20 per share. The expected gross proceeds from this offering amount to $11 million, which will be used for research and development, sales, and other corporate purposes. The firm shares will be sold in an offering that signifies a strategic move to raise capital for expansion and innovation.
  • : SEC 8-K (8.01): On August 20, 2026, Odysight.ai Inc. announced a firm commitment underwritten public offering of 3,437,500 shares of its common stock, with a par value of $0.001 per share. This strategic move may indicate the company's intention to raise capital for expansion or operational enhancement. The pricing details of the offering were shared in a press release attached as Exhibit 99.1. Given the size of the offering, it could have significant implications for the company's financing and investment strategies moving forward.
  • : SEC 8-K (2.02): On August 13, 2026, Odysight.ai, Inc. announced its financial results for the first half of 2026 via a press release. This update provided insights into the company’s performance, strategy, and market position. The announcement highlights key financial metrics and operational developments that reflect the current state of the business. The press release is included as Exhibit 99.1, which is referenced in this Form 8-K filing.
  • : SEC 8-K (1.01): On June 5, 2026, Odysight.ai Inc. entered into a Sales Agreement with Roth Capital Partners, LLC, allowing for the sale of up to $20,000,000 in shares of common stock through at-the-market offerings. The sales can occur at prevailing market prices or through negotiated transactions, but there is no obligation for either party to sell or purchase shares. The Agent will earn a commission of up to 3% on the gross proceeds of shares sold, and Odysight.ai will reimburse the Agent for expenses up to $75,000 for entering the agreement and $7,500 quarterly for maintenance costs. This agreement facilitates capital raising flexibility for the Company while managing associated costs and risks under specified conditions.
  • : SEC 8-K (5.02): On May 19, 2026, Odysight.ai Inc.'s Board of Directors approved an option award to Ronen Tanami, newly appointed Chief Operating Officer as of May 13, 2026. Mr. Tanami was awarded options to purchase 40,000 shares of common stock at an exercise price of $5.09 per share, pursuant to the Company’s 2024 Stock Incentive Plan. The options will vest one-third on the first anniversary of the grant date, and the remaining shares will vest over two years in eight equal quarterly installments. Notably, the options are subject to acceleration of vesting in the event of a change of control of the Company.
  • : SEC 8-K (7.01): On April 10, 2026, Odysight.ai Inc. disclosed an investor presentation designed for discussions with investors and analysts. The presentation is available on the company's website and will be utilized in various engagements with third parties. It is an integral tool for communicating the company’s strategic goals and financial outlook. The filing emphasizes that the information is furnished rather than filed under the Exchange Act, indicating there are no liabilities associated within this communication, which is critical for maintaining regulatory compliance.
  • : SEC 8-K (8.01): On March 31, 2026, ODYSIGHT.AI INC. announced the listing of its common stock on the Tel Aviv Stock Exchange (TASE), with trading expected to commence on April 9, 2026. This dual listing will occur alongside its existing listing on the Nasdaq Capital Market under the ticker symbol ODYS, also represented in Hebrew as 'אודס'. This strategic move aims to increase market visibility and accessibility to a broader range of investors in Israel.
  • : SEC 8-K (7.01): On January 5, 2026, Odysight.AI Inc. issued a press release to announce the posting of a CEO letter to shareholders on the company's investor relations website. This disclosure is intended to inform shareholders and stakeholders of important company updates directly from the CEO, enhancing transparency and communication. The letter aims to convey business updates and strategic direction, thereby impacting how investors perceive the company's performance and future trajectory. The press release is included as Exhibit 99.1 to the filing.

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Odysight.ai funding history

DateRoundAmount
Aug 2026Post-IPO Equity$11.0M

Leadership

  • Ronen Tanami, Chief Operating Officer
  • Eilam Sagi, Chief Business Officer
  • Einav Brenner, Chief Financial Officer
  • Tanya Yosef, Vice President of Finance
  • Eli Israeli, Chief Technology Officer

Verified email and direct lines for Odysight.ai’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Odysight.ai in the news

Companies similar to Odysight.ai

  • AKASA · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Machine Learning, Medical, Software
  • Scarlet · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Medical, Medical Device, Software
  • Soombit AI · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Medical, Medical Device, Software
  • Laza Medical · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Medical, Medical Device, Software
  • AIBORN Ltd · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Medical, Medical Device, Software

About Odysight.ai: questions and answers

What does Odysight.ai do?

Odysight.ai is pioneering the Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) markets with its visualization and AI platform. Providing video sensor-based solutions for critical systems in the aviation, transportation, and energy industries, Odysight.ai leverages proven visual technologies and products from the medical industry. Odysight.ai’s unique video-based sensors, embedded

Where is Odysight.ai headquartered?

Odysight.ai is headquartered in Omer, Israel.

How many employees does Odysight.ai have?

Odysight.ai has about 56 employees.

Has Odysight.ai raised funding?

Yes. Fundz has recorded 1 funding event for Odysight.ai. The most recent, Post-IPO Equity of $11.0M, was in Aug 2026.

Who leads Odysight.ai?

Tanya Yosef is a Vice President of Finance at Odysight.ai.

What is the latest news on Odysight.ai?

On Aug 21, 2026, Odysight.ai Inc. Secures $11 Million in Public Offering

Is Odysight.ai a public company?

Yes. Odysight.ai is publicly traded under the ticker ODYS.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Odysight.ai across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.